Related Experiment Video
Updated: Jun 2, 2026
09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MicroRNA involvement in immune activation during heart failure
Mathijs van de Vrie1, Stephane Heymans, Blanche Schroen
1Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, PO Box 5800, 6202, AZ Maastricht, The Netherlands.
Cardiovascular Drugs and Therapy
|April 20, 2011
Summary
Chronic immune activation and microRNA (miRNA) dysregulation are hallmarks of heart failure. This review explores their interplay, suggesting potential therapeutic targets for this cardiovascular disease.
Area of Science:
- Cardiovascular Diseases
- Immunology
- Molecular Biology
Background:
- Heart failure is a leading cause of death, with underlying molecular mechanisms often unclear.
- Failing hearts exhibit chronic immune activation and altered microRNA (miRNA) expression.
- Inflammatory pathways like TLR4 signaling and cytokines (IL-1β, TNFα, IL-6) are implicated.
Purpose of the Study:
- To review the interplay between the immune system and miRNAs in heart failure development.
- To discuss the role of inflammatory signaling and miRNA regulation in cardiac dysfunction.
- To hypothesize on the involvement of specific miRNAs in heart failure pathogenesis.
Main Methods:
- Literature review and synthesis of existing studies on heart failure, immunity, and miRNAs.
- Analysis of inflammatory markers and miRNA expression patterns in heart failure.
- Discussion of the renin-angiotensin-aldosterone system's role in immunity and heart failure.
Main Results:
- Heart failure patients show sustained innate immune activation and specific inflammatory signaling.
- MicroRNAs are critical regulators of cardiac function and inflammation.
- Differential miRNA expression is observed during heart failure development.
Conclusions:
- The interaction between immune responses and miRNAs is crucial in heart failure.
- Targeting immune pathways and associated miRNAs may offer therapeutic strategies.
- Further research is needed to validate miRNA-based interventions for heart failure.
Related Concept Videos
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...